Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-03-027515
Filing Date
2003-11-28
Accepted
2003-11-28 15:45:14
Documents
1
Period of Report
2003-11-26

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4379
  Complete submission text file 0001104659-03-027515.txt   6090
Mailing Address
Business Address 6611 DUMBARTON CIRCLE FREMONT CA 94555 5105052100
CIPHERGEN BIOSYSTEMS INC (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address MDS CAPITAL CORP 100 INTERNATIONAL BLVD TORONTO ONTARIO CANA A6 0000
Business Address
CALLAGHAN MICHAEL J (Reporting) CIK: 0001229593 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31617 | Film No.: 031028681